RecallRadar

FDA Drug recall D-0742-2026

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540,…

On 2026-07-29 the FDA classified a Class II recall of Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540,… by Bionpharma, citing presence of Foreign Tablets/Capsules.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0742-2026
ClassificationClass II
Statusongoing
Initiated2026-06-26
Published2026-07-29
Last updated2026-09-13 11:52 UTC
CompanyBionpharma
DistributionUS

Product

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.

Reason

Presence of Foreign Tablets/Capsules

Identifiers

ndc69452-433-13
ndc69452-433-20
ndc69452-433-30
ndc69452-434-13
ndc69452-434-20
ndc69452-434-30
ndc69452-435-13
ndc69452-435-20
ndc69452-435-30
code_infoLot# 704C003, Exp. 12/31/2028

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0742-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.